Status:
COMPLETED
Temperature Control in Central Fever in the Neuro-ICU
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Gaymar Industries, Inc.
Conditions:
Fever
Brain Hemorrhage
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
There are few treatments for central fever (fever that is due to the central nervous system, as opposed to an infectious source). We hypothesize that an externally applied cooling blanket will reduce ...
Eligibility Criteria
Inclusion
- Two or more days with core temperature ≥ 100.4F
- Approval of the patient's primary attending physician
- Need for core temperature measurement independent of the study.
- Admission to the Neuro-ICU \[intensive care unit\] for an underlying condition
Exclusion
- Evidence for an infectious cause of fever, such as pneumonia, bacteremia, CNS \[central nervous system\] infection or urinary tract infection.
- Expected death from any cause
- Known sensitivity to the device
- History of pre-admission hypothalamic dysfunction or known temperature dysregulation
- Use of 2 or more vasopressor medications, since this may make a local skin reaction to the device more likely
- Hemodynamic instability
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00751634
Start Date
January 1 2009
End Date
January 1 2011
Last Update
May 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611